Trials / Completed
CompletedNCT05807906
The Effect of Virtual Reality Application on Pain Due to Fistula Puncture in Hemodialysis Patients
The Effect of Virtual Reality Application on Fistula Puncture Associated Pain in Hemodialysis Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Hacettepe University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to examine the effect of virtual reality application on fistula puncture-related pain (FPi-A) in hemodialysis patients. Hypotheses of the Research: H0-1: Virtual reality application has an effect on fistula puncture-related pain in HD patients. H1-2: Virtual reality application has no effect on fistula puncture-related pain in HD patients. In the study, virtual reality will be applied in the fistula puncture procedure in patients receiving hemodialysis treatment.
Detailed description
* Demographic/medical data will initially be recorded prior to fistula puncture. * The patient will be prepared for the virtual reality application and fistula puncture and will be given a comfortable sitting position. * Virtual reality glasses will be put on the patient 6 minutes before the fistula puncture and the application will be started. * The patient will continue to monitor the virtual reality application during the fistula puncture procedure. It will be ensured that no communication with the patient is made until the application is finished. * The application will be ended with the fixation of the needle on the fistula after the fistula puncture procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | virtual reality application | The patient will continue to monitor the virtual reality application during the fistula puncture procedure. |
Timeline
- Start date
- 2023-04-17
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
- First posted
- 2023-04-11
- Last updated
- 2024-02-28
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05807906. Inclusion in this directory is not an endorsement.